Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Moodys
Express Scripts
Baxter
Mallinckrodt
Fuji
Boehringer Ingelheim
UBS
Farmers Insurance
US Department of Justice

Generated: December 10, 2017

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Sweden Patent: 9804211

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Astrazeneca PharmsBRILINTAticagrelorTABLET;ORAL022433-002Sep 3, 2015RXYesNo► Subscribe► Subscribe► SubscribeYY
Astrazeneca PharmsBRILINTAticagrelorTABLET;ORAL022433-001Jul 20, 2011RXYesYes► Subscribe► Subscribe► SubscribeYY
Astrazeneca PharmsBRILINTAticagrelorTABLET;ORAL022433-002Sep 3, 2015RXYesNo► Subscribe► Subscribe► SubscribeYYYREDUCTION OF THE RATE OF CARDIOVASCULAR DEATH, MYOCARDIAL INFARCTION, AND STROKE IN PATIENTS WITH ACUTE CORONARY SYNDROME OR A HISTORY OF MYOCARDIAL INFARCTION
Astrazeneca PharmsBRILINTAticagrelorTABLET;ORAL022433-002Sep 3, 2015RXYesNo► Subscribe► Subscribe► SubscribeYYYREDUCTION OF THE RATE OF THROMBOTIC EVENTS IN PATIENTS WITH ACUTE CORONARY SYNDROME
Astrazeneca PharmsBRILINTAticagrelorTABLET;ORAL022433-002Sep 3, 2015RXYesNo► Subscribe► Subscribe► SubscribeYYYTREATMENT OF STROKE
Astrazeneca PharmsBRILINTAticagrelorTABLET;ORAL022433-002Sep 3, 2015RXYesNo► Subscribe► Subscribe► SubscribeYYYTREATMENT OF POST-MYOCARDIAL INFARCTION
Astrazeneca PharmsBRILINTAticagrelorTABLET;ORAL022433-001Jul 20, 2011RXYesYes► Subscribe► Subscribe► SubscribeYYYTREATMENT OF STROKE
Astrazeneca PharmsBRILINTAticagrelorTABLET;ORAL022433-001Jul 20, 2011RXYesYes► Subscribe► Subscribe► SubscribeYYYTREATMENT OF POST-MYOCARDIAL INFARCTION
Astrazeneca PharmsBRILINTAticagrelorTABLET;ORAL022433-001Jul 20, 2011RXYesYes► Subscribe► Subscribe► SubscribeYYYREDUCTION OF THE RATE OF THROMBOTIC EVENTS IN PATIENTS WITH ACUTE CORONARY SYNDROME
Astrazeneca PharmsBRILINTAticagrelorTABLET;ORAL022433-001Jul 20, 2011RXYesYes► Subscribe► Subscribe► SubscribeYYYREDUCTION OF THE RATE OF CARDIOVASCULAR DEATH, MYOCARDIAL INFARCTION, AND STROKE IN PATIENTS WITH ACUTE CORONARY SYNDROME OR A HISTORY OF MYOCARDIAL INFARCTION
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist